Consolidated Statement Of Income

D.Western Therapeutics Institute, Inc. - Filing #7338952

Concept 2024-01-01 to
2024-03-31
2023-01-01 to
2023-03-31
Consolidated statement of income
Statement of income
Net sales
104,819,000 JPY
90,000,000 JPY
Operating expenses
Selling, general and administrative expenses
414,485,000 JPY
183,753,000 JPY
Other
67,622,000 JPY
70,578,000 JPY
Operating expenses
Cost of sales
9,128,000 JPY
7,331,000 JPY
Net sales
Gross profit (loss)
95,690,000 JPY
82,668,000 JPY
Operating profit (loss)
-318,795,000 JPY
-101,085,000 JPY
Ordinary profit (loss)
-320,454,000 JPY
-101,330,000 JPY
Operating expenses
Research and development expenses
346,863,000 JPY
113,175,000 JPY
Non-operating income
Interest income
4,000 JPY
6,000 JPY
Other
14,000 JPY
11,000 JPY
Non-operating income
2,664,000 JPY
1,219,000 JPY
Selling, general and administrative expenses
Cost of sales
Non-operating expenses
Interest expenses
869,000 JPY
626,000 JPY
Other
704,000 JPY
172,000 JPY
Non-operating expenses
4,323,000 JPY
1,464,000 JPY
Share issuance costs
JPY
665,000 JPY
Profit (loss) before income taxes
-320,454,000 JPY
-101,330,000 JPY
Gross profit
Income taxes - current
398,000 JPY
398,000 JPY
Income taxes
398,000 JPY
398,000 JPY
Profit (loss)
-320,853,000 JPY
-101,729,000 JPY
Profit (loss) attributable to non-controlling interests
JPY
-3,867,000 JPY
Profit (loss) attributable to owners of parent
-320,853,000 JPY
-97,861,000 JPY
Other comprehensive income
Valuation difference on available-for-sale securities
-106,000 JPY
94,000 JPY
Other comprehensive income
-106,000 JPY
94,000 JPY
Profit attributable to
Comprehensive income
-320,959,000 JPY
-101,634,000 JPY
Comprehensive income attributable to
Comprehensive income attributable to owners of parent
-320,959,000 JPY
-97,766,000 JPY
Comprehensive income attributable to non-controlling interests
JPY
-3,867,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.